哈洛佩里多尔诱导的失智症及其与小鼠不同大脑结构中的乙胆酶活性之间的相关性
Brenda Rufino da Silva1, Joyce Maria Ferreira Alexandre Lima1, Marcela Bermudez Echeverry2
1Natural and Humanities Sciences Center (CCNH), Experimental Morphophysiology Laboratory, Federal University of ABC (UFABC), São Bernardo do Campo 09606-070, Brazil.
Neurology international
|December 27, 2024
概括
利 (Hal) 可以通过抑制乙胆酶 (AChE),增加乙胆 (ACh) 水平来治疗痴呆症症状. 这项研究调查了哈尔的研究.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 抗精神病药物,如Haloperidol (Hal) 治疗心理障碍,但可能导致运动副作用 (EPS),如触觉.
- 利的机制涉及阻断D2受体,导致乙胆 (ACh) 的释放,然后由乙胆酶 (AChE) 水解.
研究的目的:
- 为了研究Haloperidol在关键小鼠大脑区域的ACHE活性上的抑制作用.
- 为了探索Haloperidol诱导的催眠症及其ACHE抑制作用之间的关系.
主要方法:
- 在男性瑞士小鼠身上进行了ex vivo和in vivo测试.
- 测量了AChE活动在各种大脑区域 (条形体,海马体,七角海马体系统).
- 用哈洛佩里多尔度来评估ex vivo AChE抑制 (IC50) 和体内触觉效应.
主要成果:
- 大脑中的ACHE活动分布:条纹体>海马体> (额前皮层/海马体/小脑) >脑干>七角海马系统.
- 哈洛佩里多尔以度依赖的方式抑制了在条体,海马体和海马体系统中的ACHE活性.
- 在低剂量的Haloperidol (0.01 mg·kg-1) 中,观察到降低的触感和降低海马体ACHE活性之间的积极相关性.
结论:
- 哈洛佩里多尔可以通过抑制ACHE来增强胆固醇作用,补充其多巴胺对抗作用.
- 这种ACHE抑制为管理痴呆症行为障碍提供了潜在的替代策略.
更多相关视频
相关概念视频
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...